|
1
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fimia GM, Corazzari M, Antonioli M and
Piacentini M: Ambra1 at the crossroad between autophagy and cell
death. Oncogene. 32:3311–3318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fimia GM, Stoykova A, Romagnoli A, Giunta
L, Di Bartolomeo S, Nardacci R, Corazzari M, Fuoco C, Ucar A,
Schwartz P, et al: Ambra1 regulates autophagy and development of
the nervous system. Nature. 447:1121–1125. 2007.PubMed/NCBI
|
|
4
|
Gu W, Wan D, Qian Q, Yi B, He Z, Gu Y,
Wang L and He S: Ambra1 is an essential regulator of autophagy and
apoptosis in SW620 cells: Pro-survival role of Ambra1. PLoS One.
9:e901512014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klionsky DJ: Autophagy: From phenomenology
to molecular understanding in less than a decade. Nat Rev Mol Cell
Biol. 8:931–937. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kroemer G and Jäättelä M: Lysosomes and
autophagy in cell death control. Nat Rev Cancer. 5:886–897. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie ZP and Klionsky DJ: Autophagosome
formation: Core machinery and adaptation. Nat Cell Biol.
9:1102–1109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Levine B: Cell biology: Autophagy and
cancer. Nature. 446:745–747. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ravikumar B, Futter M, Jahreiss L,
Korolchuk VI, Lichtenberg M, Luo S, Massey DC, Menzies FM,
Narayanan U, Renna M, et al: Mammalian macroautophagy at a glance.
J Cell Sci. 122:1707–1711. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baehrecke EH: Autophagy: Dual roles in
life and death? Nat Rev Mol Cell Biol. 6:505–510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Levine B and Yuan J: Autophagy in cell
death: An innocent convict? J Clin Invest. 115:2679–2688. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: Crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mizushima N, Yoshimori T and Ohsumi Y: The
role of Atg proteins in autophagosome formation. Annu Rev Cell Dev
Biol. 27:107–132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rubinsztein DC, Shpilka T and Elazar Z:
Mechanisms of autophagosome biogenesis. Curr Biol. 22:R29–R34.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dunlop EA and Tee AR: mTOR and autophagy:
A dynamic relationship governed by nutrients and energy. Semin Cell
Dev Biol. 36:121–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wong PM, Puente C, Ganley IG and Jiang XJ:
The ULK1 complex: Sensing nutrient signals for autophagy
activation. Autophagy. 9:124–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang R, Zeh HJ, Lotze MT and Tang D: The
Beclin 1 network regulates autophagy and apoptosis. Cell Death
Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lorin S, Hamaїb A, Mehrpour M and Codogno
P: Autophagy regulation and its role in cancer. Semin Cancer Biol.
23:361–379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Funderburk SF, Wang QJ and Yue Z: The
Beclin 1-VPS34 complex-at the crossroads of autophagy and beyond.
Trends Cell Biol. 20:355–362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maiuri MC, Criollo A, Tasdemir E, Vicencio
JM, Tajeddine N, Hickman JA, Geneste O and Kroemer G: BH3-only
proteins and BH3 mimetics induce autophagy by competitively
disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X (L).
Autophagy. 3:374–376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sinha S and Levine B: The autophagy
effector Beclin 1: A novel BH3-only protein. Oncogene. 27(Suppl 1):
S137–S148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu LL, Cheng Y and Liu B: Beclin-1:
Autophagic regulator and therapeutic target in cancer. Int J
Biochem Cell Biol. 45:921–924. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Toton E, Lisiak N, Sawicka P and
Rybczynska M: Beclin-1 and its role as a target for anticancer
therapy. J Physiol Pharmacol. 65:459–467. 2014.PubMed/NCBI
|
|
26
|
He C and Levine B: The Beclin 1
interactome. Curr Opin Cell Biol. 22:140–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsunaga K, Saitoh T, Tabata K, Omori H,
Satoh T, Kurotori N, Maejima I, Shirahama-Noda K, Ichimura T, Isobe
T, et al: Two Beclin 1-binding proteins, Atg14L and Rubicon,
reciprocally regulate autophagy at different stages. Nat Cell Biol.
11:385–396. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Itakura E, Kishi C, Inoue K and Mizushima
N: Beclin 1 forms two distinct phosphatidylinositol 3-kinase
complexes with mammalian Atg14 and UVRAG. Mol Biol Cell.
19:5360–5372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choi KS: Autophagy and cancer. Exp Mol
Med. 44:109–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Corazzari M, Fimia GM and Piacentini M:
Dismantling the autophagic arsenal when it is time to die:
Concerted AMBRA1 degradation by caspases and calpains. Autophagy.
8:1255–1257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shingu T, Fujiwara K, Bögler O, Akiyama Y,
Moritake K, Shinojima N, Yokoyama T and Kondo S: Inhibition of
autophagy at a late stage enhances imatinib-induced cytotoxicity in
human malignant glioma cells. Int J Cancer. 124:1060–1071. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiong HY, Guo XL, Bu XX, Zhang SS, Ma NN,
Song JR, Hu F, Tao SF, Sun K, Li R, et al: Autophagic cell death
induced by 5-FU in Bax or PUMA deficient human colon cancer cell.
Cancer Lett. 288:68–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee YJ, Won AJ, Lee J, Jung JH, Yoon S,
Lee BM and Kim HS: Molecular mechanism of SAHA on regulation of
autophagic cell death in tamoxifen-resistant MCF-7 breast cancer
cells. Int J Med Sci. 9:881–893. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tai WT, Shiau CW, Chen HL, Liu CY, Lin CS,
Cheng AL, Chen PJ and Chen KF: Mcl-1-dependent activation of Beclin
1 mediates autophagic cell death induced by sorafenib and SC-59 in
hepatocellular carcinoma cells. Cell Death Dis. 4:e4852013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li J, Hou N, Faried A, Tsutsumi S and
Kuwano H: Inhibition of autophagy augments 5-fluorouracil
chemotherapy in human colon cancer in vitro and in vivo model. Eur
J Cancer. 46:1900–1909. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de la Cruz-Morcillo MA, Valero ML,
Callejas-Valera JL, Arias-González L, Melgar-Rojas P, Galán-Moya
EM, García-Gil E, García-Cano J and Sánchez-Prieto R: P38MAPK is a
major determinant of the balance between apoptosis and autophagy
triggered by 5-fluorouracil: Implication in resistance. Oncogene.
31:1073–1085. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sasaki K, Tsuno NH, Sunami E, Tsurita G,
Kawai K, Okaji Y, Nishikawa T, Shuno Y, Hongo K, Hiyoshi M, et al:
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on
colon cancer cells. BMC Cancer. 10:3702010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sasaki K, Tsuno NH, Sunami E, Kawai K,
Hongo K, Hiyoshi M, Kaneko M, Murono K, Tada N, Nirei T, et al:
Resistance of colon cancer to 5-fluorouracil may be overcome by
combination with chloroquine, an in vivo study. Anticancer Drugs.
23:675–682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang PM, Liu YL, Lin YC, Shun CT, Wu MS
and Chen CC: Inhibition of autophagy enhances anticancer effects of
atorvastatin in digestive malignancies. Cancer Res. 70:7699–7709.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Paillas S, Causse A, Marzi L, de Medina P,
Poirot M, Denis V, Vezzio-Vie N, Espert L, Arzouk H, Coquelle A, et
al: MAPK14/p38α confers irinotecan resistance to TP53-defective
cells by inducing survival autophagy. Autophagy. 8:1098–1112. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu D, Yang Y, Liu Q and Wang J:
Inhibition of autophagy by 3-MA potentiates cisplatin-induced
apoptosis in esophageal squamous cell carcinoma cells. Med Oncol.
28:105–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ding ZB, Hui B, Shi YH, Zhou J, Peng YF,
Gu CY, Yang H, Shi GM, Ke AW, Wang XY, et al: Autophagy activation
in hepatocellular carcinoma contributes to the tolerance of
oxaliplatin via reactive oxygen species modulation. Clin Cancer
Res. 17:6229–6238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo XL, Li D, Sun K, Wang J, Liu Y, Song
JR, Zhao QD, Zhang SS, Deng WJ, Zhao X, et al: Inhibition of
autophagy enhances anticancer effects of bevacizumab in
hepatocarcinoma. J Mol Med (Berl). 91:473–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke
AW, Wang XY, Dai Z, Peng YF, Gu CY, et al: Targeting autophagy
enhances sorafenib lethality for hepatocellular carcinoma via ER
stress-related apoptosis. Autophagy. 7:1159–1172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao M, Yang M, Yang L, Yu Y, Xie M, Zhu
S, Kang R, Tang D, Jiang Z, Yuan W, et al: HMGB1 regulates
autophagy through increasing transcriptional activities of JNK and
ERK in human myeloid leukemia cells. BMB Rep. 44:601–606. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Han W, Pan H, Chen Y, Sun J, Wang Y, Li J,
Ge W, Feng L, Lin X, Wang X, et al: EGFR tyrosine kinase inhibitors
activate autophagy as a cytoprotective response in human lung
cancer cells. PLoS One. 6:e186912011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang Y, Peng RQ, Li DD, Ding Y, Wu XQ,
Zeng YX, Zhu XF and Zhang XS: Chloroquine enhances the cytotoxicity
of topotecan by inhibiting autophagy in lung cancer cells. Chin J
Cancer. 30:690–700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kang R, Tang D, Schapiro NE, Livesey KM,
Farkas A, Loughran P, Bierhaus A, Lotze MT and Zeh HJ: The receptor
for advanced glycation end products (RAGE) sustains autophagy and
limits apoptosis, promoting pancreatic tumor cell survival. Cell
Death Differ. 17:666–676. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shin SW, Kim SY and Park JW: Autophagy
inhibition enhances ursolic acid-induced apoptosis in PC3 cells.
Biochim Biophys Acta. 1823:451–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schoenlein PV, Periyasamy-Thandavan S,
Samaddar JS, Jackson WH and Barrett JT: Autophagy facilitates the
progression of ERalpha-positive breast cancer cells to antiestrogen
resistance. Autophagy. 5:400–403. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
O'Donovan TR, O'Sullivan GC and McKenna
SL: Induction of autophagy by drug-resistant esophageal cancer
cells promotes their survival and recovery following treatment with
chemotherapeutics. Autophagy. 7:509–524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen YS, Song HX, Lu Y, Li X, Chen T,
Zhang Y, Xue JX, Liu H, Kan B, Yang G and Fu T: Autophagy
inhibition contributes to radiation sensitization of esophageal
squamous carcinoma cells. Dis Esophagus. 24:437–443. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xu CX, Zhao L, Yue P, Fang G, Tao H,
Owonikoko TK, Ramalingam SS, Khuri FR and Sun SY: Augmentation of
NVP-BEZ235′s anticancer activity against human lung cancer cells by
blockage of autophagy. Cancer Biol Ther. 12:549–555. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mirzoeva OK, Hann B, Hom YK, Debnath J,
Aftab D, Shokat K and Korn WM: Autophagy suppression promotes
apoptotic cell death in response to inhibition of the PI3K-mTOR
pathway in pancreatic adenocarcinoma. J Mol Med (Berl). 89:877–889.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xu WH, Liu ZB, Hou YF, Hong Q, Hu DL and
Shao ZM: Inhibition of autophagy enhances the cytotoxic effect of
PA-MSHA in breast cancer. BMC Cancer. 14:2732014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fedorko M: Effect of chloroquine on
morphology of cytoplasmic granules in maturing human leukocytes-an
ultrastructural study. J Clin Invest. 46:1932–1942. 1967.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Klionsky DJ, Baehrecke EH, Brume JH, Chu
CT, Codogno P, Cuervo AM, Debnath J, Deretic V, Elazar Z, Eskelinen
EL, et al: A comprehensive glossary of autophagy-related molecules
and processes (II edition). Autophagy. 7:1273–1294. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gottesman MM: Mechanisms of cancer drug
resistance. Annu Rev Med. 53:615–627. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Szakács G, Paterson JK, Ludwig JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Sun WL, Chen J, Wang YP and Zheng H:
Autophagy protects breast cancer cells from epirubicin-induced
apoptosis and facilitates epirubicin-resistance development.
Autophagy. 7:1035–1044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sun WL, Lan D, Gan TQ and Cai ZW:
Autophagy facilitates multidrug resistance development through
inhibition of apoptosis in breast cancer cells. Neoplasma.
62:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chittaranjan S, Bortnik S, Dragowska WH,
Xu J, Abeysundara N, Leung A, Go NE, DeVorkin L, Weppler SA, Gelmon
K, et al: Autophagy inhibition augments the anticancer effects of
epirubicin treatment in anthracycline-sensitive and -resistant
triple-negative breast cancer. Clin Cancer Res. 20:3159–3173. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Samaddar JS, Gaddy VT, Duplantier J,
Thandavan SP, Shah M, Smith MJ, Browning D, Rawson J, Smith SB,
Barrett JT and Schoenlein PV: A role for macroautophagy in
protection against 4-hydroxytamoxifen-induced cell death and the
development of antiestrogen resistance. Mol Cancer Ther.
7:2977–2987. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Vazquez-Martin A, Oliveras-Ferraros C and
Menendez JA: Autophagy facilitates the development of breast cancer
resistance to the anti-HER2 monoclonal antibody trastuzumab. PLoS
ONE. 4:e62512009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ajabnoor GM, Crook T and Coley HM:
Paclitaxel resistance is associated with switch from apoptotic to
autophagic cell death in MCF-7 breast cancer cells. Cell Death Dis.
3:e2602012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Di Bartolomeo S, Corazzari M, Nazio F,
Oliverio S, Lisi G, Antonioli M, Pagliarini V, Matteoni S, Fuoco C,
Giunta L, et al: The dynamic interaction of AMBRA1 with the dynein
motor complex regulates mammalian autophagy. J Cell Biol.
191:155–168. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Nazio F, Strappazzon F, Antonioli M,
Bielli P, Cianfanelli V, Bordi M, Gretzmeier C, Dengjel J,
Piacentini M, Fimia GM and Cecconi F: mTOR inhibits autophagy by
controlling ULK1 ubiquitylation, self-association and function
through AMBRA1 and TRAF6. Nat Cell Bio. 15:406–416. 2013.
View Article : Google Scholar
|
|
68
|
Strappazzon F, Vietri-Rudan M, Campello S,
Nazio F, Florenzano F, Fimia GM, Piacentini M, Levine B and Cecconi
F: Mitochondrial BCL-2 inhibits AMBRA1-induced autophagy. EMBO J.
30:1195–1208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Tooze1 SA and Codogno P: Compartmentalized
regulation of autophagy regulators: Fine-tuning AMBRA1 by Bcl-2.
EMBO J. 30:1185–1186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Xia P, Wang S, Du Y, Zhao Z, Shi L, Sun L,
Huang G, Ye B, Li C, Dai Z, et al: WASH inhibits autophagy through
suppression of Beclin 1 ubiquitination. EMBO J. 32:2685–2696. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Xia P, Wang S, Huang G, Du Y, Zhu P, Li M
and Fan Z: RNF2 is recruited by WASH to ubiquitinate AMBRA1 leading
to downregulation of autophagy. Cell Res. 24:943–958. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Abrahamsen H, Stenmark H and Platta HW:
Ubiquitination and phosphorylation of Beclin 1 and its binding
partners: Tuning class III phosphatidylinositol 3-kinase activity
and tumor suppression. FEBS Lett. 586:1584–1591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yazdankhah M, Farioli-Vecchioli S, Tonchev
AB, Stoykova A and Cecconi F: The autophagy regulators Ambra1 and
Beclin 1 are required for adult neurogenesis in the brain
subventricular zone. Cell Death Dis. 5:e14032014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Pagliarini V, Wirawan E, Romagnoli A,
Ciccosanti F, Lisi G, Lippens S, Cecconi F, Fimia GM, Vandenabeele
P, Corazzari M and Piacentini M: Proteolysis of Ambra1 during
apoptosis has a role in the inhibition of the autophagic
pro-survival response. Cell Death Differ. 19:1495–1504. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Booth LA, Tavallai S, Hamed HA,
Cruickshanks N and Dent P: The role of cell signalling in the
crosstalk between autophagy and apoptosis. Cell Signal. 26:549–555.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Hou W, Han J, Lu C, Goldstein LA and
Rabinowich H: Autophagic degradation of active caspase-8: A
crosstalk mechanism between autophagy and apoptosis. Autophagy.
6:891–900. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ko YH, Cho YS, Won HS, Jeon EK, An HJ,
Hong SU, Park JH and Lee MA: Prognostic significance of
autophagy-related protein expression in resected pancreatic ductal
adenocarcinoma. Pancreas. 42:829–835. 2013. View Article : Google Scholar : PubMed/NCBI
|
